Management of morphologic changes associated with antiretroviral use in HIV-infected patients.

Journal of acquired immune deficiency syndromes (1999)

Volumn 49 Suppl 2, Issue , 2008, Pages

  Wohl, David Alain ^a   Brown, Todd T ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

BODY FAT DISTRIBUTION; CARDIOVASCULAR DISEASE; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; HIV ASSOCIATED LIPODYSTROPHY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PATHOLOGY; REVIEW; RISK FACTOR;

ANTI-HIV AGENTS; BODY FAT DISTRIBUTION; CARDIOVASCULAR DISEASES; CLINICAL TRIALS AS TOPIC; HIV INFECTIONS; HIV-ASSOCIATED LIPODYSTROPHY SYNDROME; HUMANS; RISK FACTORS;

EID: 53449087849     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e318186521a     Document Type: Review

References (70)